Results for "**Rare disease**"
Conditions Encyclopedia Entry 1777194245
** This entry is about a rare genetic disorder known as **Ehlers-Danlos Syndrome (EDS)**, a group of disorders that affect the body's connective tissue. ## Overview Ehlers-Danlos Syndrome (EDS) is a rare genetic disorder characterized by extremely flexible joints, skin hyperextensibility, and tissue fragility. It affects approximately 1 in 5,000 to 1 in 20,000 people worldwide. EDS is caused by mutations in genes that code for proteins responsible for the production of collagen, a key component of connective tissue. This tissue provides support and structure to various parts of the body, including skin, bones, tendons, and ligaments. People with EDS often experience a range of symptoms, including joint hypermobility, easy bruising, and poor wound healing. They may also experience gastrointestinal issues, such as constipation or bowel obstruction, and may be at a higher risk of developing certain types of cancer, including gastrointestinal and ovarian cancer. In severe cases, EDS can lead to life-threatening complications, such as rupture of major blood vessels or organs. ## History/Background The first reported case of EDS was in 1901 by a dermatologist named Edward Ehlers. However, it was not until the 1930s that the condition was more fully described by another dermatologist, Henri-Alexandre Danlos. Since then, research has led to a better understanding of the genetic causes of EDS and the development of diagnostic criteria. In 1996, the International Classification of EDS was established, which categorizes the condition into 13 subtypes based on the type of mutation and the severity of symptoms. ## Key Information There are 13 subtypes of EDS, each with distinct characteristics and symptoms. The most common subtypes are: * Classical EDS (cEDS): characterized by skin hyperextensibility and joint hypermobility * Hypermobile EDS (hEDS): characterized by joint hypermobility and musculoskeletal pain * Vascular EDS (vEDS): characterized by fragile blood vessels and a high risk of rupture People with EDS often experience a range of complications, including: * Joint dislocations and subluxations * Gastrointestinal issues, such as constipation or bowel obstruction * Poor wound healing * Easy bruising * Increased risk of certain types of cancer ## Significance Ehlers-Danlos Syndrome is a significant condition that affects the lives of millions of people worldwide. It is essential to raise awareness about EDS to promote early diagnosis and treatment, which can improve quality of life and prevent life-threatening complications. Research into the genetic causes of EDS has also led to a better understanding of the role of collagen in the body and has implications for the treatment of other conditions, such as osteogenesis imperfecta and scleroderma. INFOBOX: - **Name:** Ehlers-Danlos Syndrome - **Type:** Genetic disorder - **Date:** 1901 (first reported case) - **Location:** Worldwide - **Known For:** Extremely flexible joints, skin hyperextensibility, and tissue fragility TAGS: **Genetic disorder**, **Connective tissue**, **Collagen**, **Joint hypermobility**, **Skin hyperextensibility**, **Tissue fragility**, **Rare disease**, **Genetic mutation**
Health & MedicineConditions Encyclopedia Entry 1777798821
** This article discusses **Mitochondrial Myopathies**, a group of rare genetic disorders affecting the mitochondria, the energy-producing structures within cells, leading to muscle weakness and other systemic symptoms. ## Overview Mitochondrial Myopathies (MMs) are a group of rare genetic disorders caused by mutations in the mitochondrial DNA (mtDNA). These mutations affect the mitochondria's ability to produce energy, leading to a range of symptoms, including muscle weakness, fatigue, and other systemic problems. MMs are often inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene is enough to cause the condition. The symptoms of MMs can vary widely depending on the specific mutation and the individual affected. MMs are characterized by a range of symptoms, including muscle weakness, particularly in the muscles of the face, arms, and legs. Other symptoms may include fatigue, shortness of breath, and swallowing difficulties. Some individuals with MMs may also experience seizures, hearing loss, and vision problems. In severe cases, MMs can lead to life-threatening complications, such as cardiac arrest and respiratory failure. Diagnosing MMs can be challenging, as the symptoms are often nonspecific and can be similar to those of other conditions. A diagnosis is typically made through a combination of genetic testing, muscle biopsy, and other diagnostic tests. Treatment for MMs is often focused on managing symptoms and improving quality of life, rather than curing the underlying condition. ## History/Background The first descriptions of MMs date back to the 1960s, when researchers identified a group of patients with muscle weakness and other systemic symptoms. Over the years, further research has led to a greater understanding of the genetic basis of MMs and the development of new diagnostic and treatment options. In the 1980s, researchers discovered that MMs were caused by mutations in the mtDNA. This breakthrough led to the development of genetic testing for MMs, which has become an essential tool in diagnosis. In the 1990s, researchers identified several key genes associated with MMs, including the **MT-ND1** gene, which is involved in the production of energy in the mitochondria. ## Key Information * **Prevalence:** MMs are rare, affecting approximately 1 in 5,000 to 1 in 10,000 people worldwide. * **Genetics:** MMs are caused by mutations in the mtDNA, which is inherited from one's parents. * **Symptoms:** Muscle weakness, fatigue, shortness of breath, swallowing difficulties, seizures, hearing loss, and vision problems. * **Diagnostic tests:** Genetic testing, muscle biopsy, and other diagnostic tests. * **Treatment:** Symptom management, including physical therapy, speech therapy, and medication to manage symptoms. ## Significance MMs are significant because they highlight the importance of mitochondrial function in maintaining overall health. The symptoms of MMs can have a profound impact on an individual's quality of life, making it essential to develop effective treatments and management strategies. Research into MMs has also led to a greater understanding of the genetic basis of other conditions, such as Alzheimer's disease and Parkinson's disease. INFOBOX: - **Name:** Mitochondrial Myopathies - **Type:** Genetic disorder - **Date:** 1960s (first descriptions) - **Location:** Worldwide - **Known For:** Rare genetic disorder affecting mitochondrial function TAGS: **Mitochondrial Myopathies**, **Genetic disorder**, **Mitochondrial function**, **Muscle weakness**, **Fatigue**, **Symptom management**, **Genetic testing**, **Rare disease**
Health & MedicineConditions Encyclopedia Entry 1779619505
** This entry is about a rare genetic disorder known as **Erythromelalgia**, a condition characterized by burning pain, redness, and heat in the hands and feet. ## Overview Erythromelalgia is a rare genetic disorder that affects approximately 1 in 200,000 people worldwide. It is characterized by recurring episodes of burning pain, redness, and heat in the hands and feet, often accompanied by increased skin temperature. The condition can be debilitating and significantly impact a person's quality of life. Erythromelalgia is often misdiagnosed or underdiagnosed, leading to delayed treatment and inadequate management of symptoms. The symptoms of erythromelalgia can vary in severity and may be triggered by factors such as heat, exercise, or stress. Some people may experience mild symptoms, while others may experience severe and debilitating episodes. In addition to the physical symptoms, erythromelalgia can also have a significant emotional and psychological impact on those affected, leading to anxiety, depression, and social isolation. ## History/Background Erythromelalgia was first described in the medical literature in the late 19th century by a German physician named **Heinrich Quincke**. However, it was not until the 1960s that the condition was more fully characterized and understood. In the 1980s, researchers identified the genetic mutations responsible for the condition, which are associated with defects in the **ENPP1** gene. This discovery has led to a greater understanding of the condition and the development of more effective treatments. ## Key Information Erythromelalgia is a genetic disorder that is inherited in an **autosomal dominant** pattern, meaning that a single copy of the mutated gene is sufficient to cause the condition. The condition is caused by defects in the **ENPP1** gene, which codes for an enzyme involved in the regulation of **pyrophosphate** levels in the body. Elevated pyrophosphate levels can lead to the symptoms of erythromelalgia, including burning pain, redness, and heat. There are two main types of erythromelalgia: **familial** and **primary**. Familial erythromelalgia is inherited in an autosomal dominant pattern and is caused by mutations in the **ENPP1** gene. Primary erythromelalgia is a rare form of the condition that is not inherited and is often associated with other medical conditions, such as **multiple sclerosis** or **Parkinson's disease**. ## Significance Erythromelalgia is a significant condition that affects the quality of life of those affected. The condition can be debilitating and may lead to social isolation, anxiety, and depression. Early diagnosis and treatment are essential to managing symptoms and improving quality of life. ## InfoBox: - **Name:** Erythromelalgia - **Type:** Genetic disorder - **Date:** First described in the late 19th century - **Location:** Worldwide - **Known For:** Rare genetic disorder characterized by burning pain, redness, and heat in the hands and feet ## TAGS: **Genetic disorder**, **Rare disease**, **Pain management**, **Heat intolerance**, **Genetic mutations**, **ENPP1 gene**, **Autosomal dominant inheritance**, **Quality of life**, **Medical research**, **Neurological disorders**